Xin-Yuan Liu (Xinyuan Liu)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Radiation Therapy

Top Venues

Cancer immunology, immunotherapy : CII

Journal of cellular and molecular medicine

Human gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hai-Jun Hu, Xiu Liang, Hai-Lang Li, Huai-Yuan Wang, Jin-Fa Gu, Lan-Ying Sun, Jing Xiao, Jin-Qing Hu, Ai-Min Ni, Xin-Yuan Liu
Optimization of the Administration Strategy for the Armed Oncolytic Adenovirus ZD55-IL-24 in Both Immunocompromised and Immunocompetent Mouse Models. Human gene therapy (2021)
Hai-Jun Hu, Xiu Liang, Hai-Lang Li, Huai-Yuan Wang, Jin-Fa Gu, Lan-Ying Sun, Jing Xiao, Jin-Qing Hu, Ai-Min Ni, Xin-Yuan Liu
Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model. Cancer immunology, immunotherapy : CII 70 (12) (2021)
Boduan Xiao, Chang Ying, Yongyi Chen, Fang Huang, Binrong Wang, Huiling Fang, Wan Guo, Tao Liu, Xiumei Zhou, Biao Huang, Xin-Yuan Liu, Yigang Wang
Doxorubicin hydrochloride enhanced antitumour effect of CEA-regulated oncolytic virotherapy in live cancer cells and a mouse model. Journal of cellular and molecular medicine 24 (22) (2020)
Yuan-Qin Yang, Wen-Jie Dong, Xiao-Fei Yin, Yan-Ni Xu, Yu Yang, Jiao-Jiao Wang, Su-Jing Yuan, Jing Xiao, Jonathan Howard DeLong, Liang Chu, Hai-Neng Xu, Xiu-Mei Zhou, Ru-Wei Wang, Ling Fang, Xin-Yuan Liu, Kang-Jian Zhang
Interferon-related secretome from direct interaction between immune cells and tumor cells is required for upregulation of PD-L1 in tumor cells. Protein & cell 7 (7) (2018)